Pricing Log in Create free account

Anebulo Pharmaceuticals, Inc. (ANEB) vs Jasper Therapeutics, Inc. (JSPR)

Anebulo Pharmaceuticals, Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Jasper Therapeutics, Inc. are of similar size ($17.7M and $17.6M). Across the 7 metrics below, Anebulo Pharmaceuticals, Inc. leads on 6 and Jasper Therapeutics, Inc. on 1.

Valuation

Metric ANEB JSPR Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 9.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.03 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (331.25%) (33.15%)
Free cash flow yield 0.00% (437.42%) (25.50%)

Profitability

Metric ANEB JSPR Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.69%) (255.05%) (56.36%)
Return on assets (63.17%) (109.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANEB JSPR Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 21.88% 19.22% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANEB JSPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.24 1.48 4.72
Net debt to EBITDA 1.32 0.35 0.96

Dividend

Metric ANEB JSPR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANEB JSPR Biotechnology median
Market cap 17.60m 17.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack